Prof. ŞULE MİNE BAKANAY ÖZTÜRK

Publication Network

Articles 36

1. Real-Life Retrospective Turkiye Data of the De-Escalation of ABVD to AVD in Hodgkin Lymphoma: On Behalf of the TSH Turkish Lymphoma Study Group

Isleyen E., Alhan N., Terzi Demirsoy E., Geduk A., Avci D. N., Yeral M., et al.

JOURNAL OF CLINICAL MEDICINE , vol.14, no.19, pp.1-12, 2025 (SCI-Expanded, Scopus)

2. Does CD47 expression have prognostic significance in classical Hodgkin lymphoma?

KILIÇARSLAN A., Kurt Çevik G., DOĞAN M., AKSOY ALTINBOĞA A., Ceran F., Efecik G., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.55, no.1, pp.203-208, 2025 (SCI-Expanded, Scopus, TRDizin)

3. Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry

Karakuş S., Bakanay Ş. M., BEŞIŞIK S., EŞKAZAN A. E., Ayyıldız O., GÜRKAN E., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.42, no.3, pp.203-212, 2025 (SCI-Expanded, Scopus, TRDizin)

4. A young adult patient with Philadelphia positive acute lymphoblastic leukemia presenting with extreme hyperleukocytosis

Tikit G., YÜCESU E., SARIFAKIOĞULLARI A. S., DİLEK İ., BAKANAY ÖZTÜRK Ş. M.

CLINICAL CASE REPORTS , vol.13, 2024 (ESCI)

5. Comparison of low dose cytosine arabinoside, azacitidine and azacitidine venetoclax combination treatment as remission induction in elderly acute myeloid leukemia patients

CAN F., ŞENTÜRK YIKILMAZ A., GÖKÇE D., GÜNEY T., AKINCI S., BAKANAY ÖZTÜRK Ş. M., et al.

Journal of medicine and palliative care (Online) , vol.4, no.6, pp.619-624, 2023 (TRDizin)

6. Castleman Disease: A Multicenter Case Series from Turkey

GÜNDÜZ E., Kırkızlar H. O., ÜMİT E. G., Karaman Gülsaran S., ÖZKOCAMAN V., ÖZKALEMKAŞ F., et al.

Turkish journal of haematology : official journal of Turkish Society of Haematology , vol.39, no.2, pp.130-135, 2022 (SCI-Expanded, Scopus, TRDizin)

7. **Predictive Factors for Molecular Response in Chronic Myeloid Leukemia: Reduction Ratio and Halving Time of BCR::ABL1 IS Transcript Levels**

Ceran F., Akıncı S., Uçar M. A., Korkmaz G., Gündüz M., Çavdarlı B., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.3, pp.196-203, 2022 (SCI-Expanded, Scopus, TRDizin)

8. A Rare Lymphoproliferative Disease: Castleman Disease Nadir Bir Lenfoproliferatif Hastalık: Castleman Hastalığı

GÜNDÜZ E., Özdemir N., Bakanay Ş. M., Karakuş S.

Turkish Journal of Hematology , vol.38, no.4, pp.314-320, 2021 (SCI-Expanded, Scopus, TRDizin)

9. Relationship between mannose-binding lectin and febrile neutropenia in acute leukemia patients

Akan S., Bakanay Ş. M., Bilen Y., Balcan B., Erdem F.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , vol.11, no.5, pp.402-405, 2020 (ESCI)

10. The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma

Ozturk V., Yikilmaz A. S., KILIÇARSLAN A., Bakanay Ş. M., Akinci S., DİLEK İ.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, no.7, 2020 (SCI-Expanded, Scopus)

11. Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib

Maral S., Bakanay Ş. M., Kucuksahin O., Dilek İ.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.26, no.3, pp.738-741, 2020 (SCI-Expanded, Scopus)

12. Vitamin D Deficiency and Janus kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera

ŞENTÜRK YIKILMAZ A., AKINCI S., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

MALAYSIAN JOURNAL OF MEDICAL SCIENCES , vol.27, 2020 (ESCI, Scopus)

13. Is Cd11c and Fmc7 Negativity in Chronic Lymphocytic Leukemia Poor Prognostic?

Şentürk Yikilmaz A., Akinci S., Bakanay Ş. M., Zengin Z. B., DİLEK İ.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.36, no.1, pp.84-90, 2020 (SCI-Expanded, Scopus)

14. The least incompatible crossmatch red blood cell transfusion by biological compatibility test

MARAL S., BAKANAY ÖZTÜRK Ş. M., AKINCI S., ŞENTÜRK YIKILMAZ A., CÖMERT P., DİLEK İ.

Global Journal of Transfusion Medicine , vol.4, 2019 (Peer-Reviewed Journal)

15. Auer rods in mature neutrophils in a case of acute promyelocytic leukemia .

KÜÇÜKYURT KAYA S., BAKANAY ÖZTÜRK Ş. M., KILIÇARSLAN A., AKINCI S., GÜNDÜZ M., DİLEK İ.

International Journal of Medical Reviews and Case Reports , 2019 (Peer-Reviewed Journal)

16. Effect of Treatment on the Muscle Mass and Response to Therapy in Hodgkin’s Lymphoma

Küçükyurt S., Bilgin B., Ruşen M. M., Yıkılmaz A. Ş., Ünal S., Gündüz M., et al.

Türkiye'de Lösemi Lenfoma Miyelom Araştırmaları , vol.3, pp.4-8, 2019 (Peer-Reviewed Journal)

17. Akut lösemili hastalarda perianal hastalıkların prevalansı ve güncel yönetimi

GÜNDÜZ M., BAKANAY ÖZTÜRK Ş. M., YAMAN S., USTA A., ÖZEN M., ŞENTÜRK YIKILMAZ A., et al.

Ortadoğu Tıp Dergisi , vol.10, no.4, pp.454-459, 2018 (TRDizin)

18. Unexpected Adverse Effect of Cloforabin Plus Cytosine Arabinoside

ŞENTÜRK YIKILMAZ A., AKINCI S., BAKANAY ÖZTÜRK Ş. M., SILAY K., DİLEK İ.

JOJ Nurse Health Care , 2018 (Peer-Reviewed Journal)

19. UNEXPECTED ADVERSE EFFECT OF CLOFARABIN PLUS CYTOSINE ARABINOSIDE: BRONZE HYPERPIGMENTATION

yıkılmaz şentürk a., akıncı s., BAKANAY ÖZTÜRK Ş. M., SILAY K., DİLEK İ.

JOJ Nurse Health Care , 2018 (Peer-Reviewed Journal)

20. Unexpected Adverse Effect of Clofarabın PlusCytosıne Arabınosıde: Bronze Hyperpıgmentatıon

ŞENTÜRK YIKILMAZ A., akincı s., BAKANAY ÖZTÜRK Ş. M., SILAY K., DİLEK İ.

JOJ Nurse Health Care , vol.6, no.5, pp.555698, 2018 (Peer-Reviewed Journal)

21. The Place of Interventional Hematologic Investigations in Unknown Fever Etiology

GÜNDÜZ M., YAMAN S., BAKANAY ÖZTÜRK Ş. M., KALEM KAYA A., KILIÇARSLAN A., ŞENTÜRK YIKILMAZ A., et al.

Ankara Medical Journal , vol.18, no.1, pp.76-83, 2018 (TRDizin)

22. Vitamin B12 Level Have Prognostic Significance inMultiple Myeloma Patients?

ŞENTÜRK YIKILMAZ A., SILAY K., akincı s., BAKANAY ÖZTÜRK Ş. M., Bekioğlu İ., DİLEK İ.

Clinics in Oncology , vol.3, pp.1434, 2018 (Peer-Reviewed Journal)

23. Aquired hemophilia with thrombosis in a cancer patient: an unusual presentation

MARAL S., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

Blood coagulation fibrinolysis , 2017 (Peer-Reviewed Journal) Sustainable Development

24. Comorbidity increases side effects of tyrosine kinase inhibitor in chronic myeloid leukemia.

AKINCI S., SILAY K., AKINCI M. B., ÖZTÜRK E., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

international journal of medical research and applications , 2017 (Peer-Reviewed Journal)

25. How to manage poor mobilizers for high dose chemotherapy and autologous stem cell transplantation?

Ataca Atilla P., Bakanay Ozturk Ş. M., DEMİRER T.

Transfusion and Apheresis Science , vol.56, no.2, pp.190-198, 2017 (SCI-Expanded, Scopus)

26. Akut hemolitik transfüzyon reaksiyonları

BAKANAY ÖZTÜRK Ş. M.

Türkiye Klinikleri Hematolojik Aciller Özel Sayısı , vol.9, no.3, pp.129-134, 2016 (TRDizin)

27. An asymptomatic chronic lymphocytic leukemia case presenting at a very young age

GÜNEY T., AKINCI S., BAKANAY ÖZTÜRK Ş. M., BAŞTÜRK A., HACIBEKİROĞLU T., DİLEK İ.

Gazi Medical Journal , 2015 (Scopus, TRDizin)

28. WE SHOULD NOT UNDERESTIMATE VITAMIN B12 AND FOLICACID DEFICIENCIES IN OLDEST OLD

AKINCI S., SILAY K., HACIBEKİROĞLU T., ULAŞ A., BAŞTÜRK A., BAKANAY ÖZTÜRK Ş. M., et al.

BASIC RESEARCH JOURNAL OF MEDICINE AND ClLINICAL SCIENCES , 2014 (Peer-Reviewed Journal)

29. EVALUATION OF PSEUDOTHROMBOCYTOPENIA CAUSES

AKINCI S., HACIBEKİROĞLU T., GÜNEY T., SILAY K., BAŞTÜRK A., BAKANAY ÖZTÜRK Ş. M., et al.

Basic Research Journal of Medicine and Clinical Sciences , 2014 (Peer-Reviewed Journal)

30. Blood group genotyping in multi-transfused patients

Bakanay Ş. M., ÖZTÜRK BİRGE A., İLERİ D. T., İNCE E., Yavasoglu S., Akar N., et al.

Transfusion and Apheresis Science , vol.48, no.2, pp.257-261, 2013 (SCI-Expanded, Scopus)

31. Diffuse plasma cell infiltration of liver detected initially at diagnosis of multiple myeloma

Guney T., Bakanay Ozturk Ş. M., Hacibekiroglu T., Akinci S., Basturk A., DİLEK İ.

CLINICA TERAPEUTICA , vol.164, no.6, 2013 (SCI-Expanded, Scopus)

32. Novel agents and approaches for stem cell mobilization in normal donors and patients

Bakanay Ş. M., DEMİRER T.

Bone Marrow Transplantation , vol.47, no.9, pp.1154-1163, 2012 (SCI-Expanded, Scopus)

33. A new sickling variant 'Hb S-Wake β[(Glu6Val-Asn139 Ser)]' found in a compound heterozygote with Hb S β(Glu6Val) coinherited with homozygous α-thalassemia-2: Phenotype and molecular characteristics

Kutlar F., Redding-Lallinger R., Meiler S., Bakanay Ş. M., Borders L., Kutlar A.

Acta Haematologica , vol.124, no.2, pp.120-124, 2010 (SCI-Expanded, Scopus)

34. Does continuous flow apheresis influence viability in allogeneic hematopoietic stem cell harvest?

Bakanay Ş. M., DALVA K., Arat M., ARSLAN Ö., Ayyildiz E., Beksac M., et al.

Transfusion and Apheresis Science , vol.34, no.2, pp.171-178, 2006 (SCI-Expanded, Scopus)

35. Mortality in sickle cell patients on hydroxyurea therapy

Bakanay Ş. M., Dainer E., Clair B., Adekile A., Daitch L., Wells L., et al.

Blood , vol.105, no.2, pp.545-547, 2005 (SCI-Expanded, Scopus)

36. Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population

Aras O., Hanson N., Bakanay Ş. M., Tsai M., Gulec S.

THROMBOSIS AND HAEMOSTASIS , vol.87, no.2, pp.347-349, 2002 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 66

1. Uzayan Ömür, uzatılmış yarı ömürlü tedaviler ile hemofili A hastasında girişimsel işlem- Sünnet- Vaka Sunumu

CAN F., KALACI G., SOYER KÖSEMEHMETOĞLU Ö., Kamacı D., AKINCI S., BAKANAY ÖZTÜRK Ş. M., et al.

Hematoloji Uzmanlık Derneği 18. Ulusal Kongresi, Turkey, 21 November 2024, (Summary Text)

2. Return to Work after Allogeneic HSCT: Further Insights in the Patients-Related Predictive Factors (The SOPRALLO Project)

Stepanishyna Y., Wittnebel S., Andreozzi F., Salaroli A., Kristanto P., Spilleboudt C., et al.

vol.144, pp.4929-4930, (Summary Text)

3. Hemofilik Psödotümör

CAN F., SARIFAKIOĞULLARI A. S., SOYER KÖSEMEHMETOĞLU Ö., AKINCI S., GÜNEY T., BAKANAY ÖZTÜRK Ş. M., et al.

7. Nadir Hastalıklar Kongresi, Cyprus (Kktc), 22 - 25 February 2024, (Summary Text)

4. FLT3 Pozitif Akut Miyeloblastik Lösemide Üçlü Tedavi

CAN F., SARIFAKIOĞULLARI A. S., SOYER KÖSEMEHMETOĞLU Ö., AKINCI S., GÜNEY T., BAKANAY ÖZTÜRK Ş. M., et al.

7. Nadir Hastalıklar Kongresi, Cyprus (Kktc), 22 - 25 February 2024, (Summary Text)

5. HİPERFERRİTİNEMİ KATARAKT SENDROMU: OLGU SUNUMU

YÜKSEL T., CAN F., GÜNEY T., AKINCI S., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

49., 01 November 2023, (Summary Text)

6. LENF NODU BİYOPSİSİNDE KRONİK LENFOSİTİK LÖSEMİ, PROSTAT KANSERİ BİRLİKTELİĞİ; VAKA SUNUMU

ALTINKAYNAK B., CAN F., AKINCI S., GÜNEY T., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

49. Ulusal Hematoloji Kongresi, 1 - 05 November 2023, (Summary Text)

7. CİLT TUTULUMU LENFOMA, VAKA SUNUMU

KARAPELİT E., CAN F., GÜNEY T., AKINCI S., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

49. Ulusal Hematoloji Kongresi, 1 - 05 November 2023, (Summary Text)

8. Hiperviskoziteye bağlı vajinal kanama ile tanı konulan plazma hücreli lösemi olgusu

Kara O., CAN F., GÜNEY T., AKINCI S., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

9. Karadeniz Hematoloji Kongresi, 16 - 17 June 2023, (Summary Text)

9. Plazma Hücreli Lösemi, Tek Merkez Deneyimi

CAN F., GÜNEY T., AKINCI S., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

6. Hematolojik Nadir Hastalıklar Kongresi, Cyprus (Kktc), 1 - 04 June 2023, (Summary Text)